Hiv/Aids

Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study | BMC Infectious Diseases

  • Global regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.

    Article 

    Google Scholar
     

  • Lucas S, Nelson AM. HIV and the spectrum of human disease. J Pathol. 2015;235:229–41.

    Article 
    PubMed 

    Google Scholar
     

  • Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV cohort study. BMJ. 1997;315:1194–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338:853–60.

    Article 
    PubMed 

    Google Scholar
     

  • Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA study group. Lancet. 1998;352:1725–30.

    Article 
    PubMed 

    Google Scholar
     

  • May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4 + cell count and viral load response to antiretroviral therapy. Aids. 2014;28:1193–202.

    Article 
    PubMed 

    Google Scholar
     

  • Pacheco YM, Jarrín I, Del AJ, et al. Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART. Curr Hiv Res. 2009;7:612–9.

    Article 
    PubMed 

    Google Scholar
     

  • Battegay M, Nüesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis. 2006;6:280–7.

    Article 
    PubMed 

    Google Scholar
     

  • Maggiolo F, Leone S. CD4 + T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection. Clin Infect Dis. 2010;51:465–7.

    Article 
    PubMed 

    Google Scholar
     

  • Young J, Psichogiou M, Meyer L, et al. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. Plos Med. 2012;9:e1001194.

    Article 
    PubMed 

    Google Scholar
     

  • Kaufmann GR, Furrer H, Ledergerber B, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to < 500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 2005;41:361–72.

    Article 
    PubMed 

    Google Scholar
     

  • Baker JV, Peng G, Rapkin J, et al. CD4 + count and risk of non-AIDS diseases following initial treatment for HIV infection. Aids. 2008;22:841–8.

    Article 
    PubMed 

    Google Scholar
     

  • Aiuti F, Mezzaroma I. Failure to reconstitute CD4 + T-cells despite suppression of HIV replication under HAART. Aids Rev. 2006;8:88–97.

    PubMed 

    Google Scholar
     

  • Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev. 1998;165:75–86.

    Article 
    PubMed 

    Google Scholar
     

  • Isgrò A, Aiuti A, Leti W, et al. Immunodysregulation of HIV disease at bone marrow level. Autoimmun Rev. 2005;4:486–90.

    Article 
    PubMed 

    Google Scholar
     

  • Isgrò A, Leti W, De Santis W, et al. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4 + T cell counts despite viral suppression during HAART. Clin Infect Dis. 2008;46:1902–10.

    Article 
    PubMed 

    Google Scholar
     

  • de la Rosa R, Leal M, Rubio A, et al. Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy. Antivir Ther. 2002;7:159–63.

    Article 
    PubMed 

    Google Scholar
     

  • Ruiz-Mateos E, Rubio A, Vallejo A, et al. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4 + T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol. 2004;136:501–6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Smith KY, Valdez H, Landay A, et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis. 2000;181:141–7.

    Article 
    PubMed 

    Google Scholar
     

  • Franco JM, Rubio A, Martínez-Moya M, et al. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood. 2002;99:3702–6.

    Article 
    PubMed 

    Google Scholar
     

  • Hunt PW, Deeks SG, Rodriguez B, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. Aids. 2003;17:1907–15.

    Article 
    PubMed 

    Google Scholar
     

  • Greenblatt R, Bacchetti P, Boylan R, et al. Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: whole exome sequencing and antiretroviral therapy response phenotypes. PLoS ONE. 2019;14:e219201.

    Article 

    Google Scholar
     

  • Tanuma J, Matsumoto S, Haneuse S et al. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam. J Int Aids Soc. 2017; 20.

  • Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV cohort study. Lancet. 2000;356:1800–5.

    Article 
    PubMed 

    Google Scholar
     

  • Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis. 2005;41:713–20.

    Article 
    PubMed 

    Google Scholar
     

  • Ma Y, Zhang F, Zhao Y, et al. Cohort profile: the Chinese national free antiretroviral treatment cohort. Int J Epidemiol. 2010;39:973–9.

    Article 
    PubMed 

    Google Scholar
     

  • Rb-Silva R, Goios A, Kelly C, et al. Definition of immunological nonresponse to antiretroviral therapy: a systematic review. J Acquir Immune Defic Syndr. 2019;82:452–61.

    Article 
    PubMed 

    Google Scholar
     

  • Moore RD, Keruly JC. CD4 + cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44:441–6.

    Article 
    PubMed 

    Google Scholar
     

  • Micheloud D, Berenguer J, Bellón JM, et al. Negative influence of age on CD4 + cell recovery after highly active antiretroviral therapy in naive HIV-1-infected patients with severe immunodeficiency. J Infect. 2008;56:130–6.

    Article 
    PubMed 

    Google Scholar
     

  • Florence E, Lundgren J, Dreezen C, et al. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. Hiv Med. 2003;4:255–62.

    Article 
    PubMed 

    Google Scholar
     

  • Viard JP, Mocroft A, Chiesi A, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis. 2001;183:1290–4.

    Article 
    PubMed 

    Google Scholar
     

  • Tumbarello M, Rabagliati R, de Gaetano DK, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:46.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peters L, Mocroft A, Soriano V, et al. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression. J Acquir Immune Defic Syndr. 2009;50:457–63.

    Article 
    PubMed 

    Google Scholar
     

  • García F, de Lazzari E, Plana M, et al. Long-term CD4 + T-cell response to highly active antiretroviral therapy according to baseline CD4 + T-cell count. J Acquir Immune Defic Syndr. 2004;36:702–13.

    Article 
    PubMed 

    Google Scholar
     

  • Nakanjako D, Ssewanyana I, Mayanja-Kizza H, et al. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis. 2011;11:43.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mussini C, Lorenzini P, Cozzi-Lepri A, et al. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2015;2:e98–106.

    Article 
    PubMed 

    Google Scholar
     

  • Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–8.

    Article 
    PubMed 

    Google Scholar
     


  • Source link

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Back to top button